Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Amie Meditz
Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Quantitation of Tenofovir and Emtricitabine in Dried Blood Spots (DBS) With LC–MS/MS
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Related publications
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Is Tenofovir/Emtricitabine Teratogenic?
Therapeutic Advances in Drug Safety
Pharmacology
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Reduction of Immune Activation With Chloroquine Therapy During Chronic HIV Infection
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
ISRN Gastroenterology
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetic and Safety Analyses of Tenofovir and Tenofovir-Emtricitabine Vaginal Tablets in Pigtailed Macaques
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Altered Metabolism of Gut Microbiota Contributes to Chronic Immune Activation in HIV-infected Individuals
Mucosal Immunology
Allergy
Immunology
